USV offers custom peptide synthesis ranging from gram to multi-gram to multi-kilogram quantities.
01 2USV Private Limited
02 1Emcure Pharmaceuticals Limited
01 3Dolasetron Mesylate
01 3India
NDC Package Code : 62147-0094
Start Marketing Date : 2009-11-17
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62147-0095
Start Marketing Date : 2009-11-17
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14593-849
Start Marketing Date : 2023-12-25
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (5kg/5kg)
Marketing Category : BULK INGREDIENT
A Dolasetron Mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dolasetron Mesylate, including repackagers and relabelers. The FDA regulates Dolasetron Mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dolasetron Mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dolasetron Mesylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dolasetron Mesylate supplier is an individual or a company that provides Dolasetron Mesylate active pharmaceutical ingredient (API) or Dolasetron Mesylate finished formulations upon request. The Dolasetron Mesylate suppliers may include Dolasetron Mesylate API manufacturers, exporters, distributors and traders.
click here to find a list of Dolasetron Mesylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Dolasetron Mesylate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Dolasetron Mesylate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Dolasetron Mesylate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Dolasetron Mesylate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Dolasetron Mesylate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Dolasetron Mesylate suppliers with NDC on PharmaCompass.
We have 2 companies offering Dolasetron Mesylate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?